BioStock: CLS not significantly affected by tariffs

Clinical Laserthermia Systems announces that the proposed U.S. tariffs are expected to have minimal impact on the company, despite the fact that its products are manufactured in the EU and shipped to the U.S. The company’s U.S. operations are fully managed by its subsidiary, CLS Americas Inc., which gives CLS control over the import process. Additionally, the company’s agreements with partners already include clear terms on how tariffs are to be handled

Read the full article at biostock.se:

https://www.biostock.se/en/2025/04/cls-not-significantly-affected-by-tariffs/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se